Leidos Holdings Insider Sold Shares Worth $2,297,945, According to a Recent SEC Filing-March 2024-www.financetom.com

Leidos Holdings Insider Sold Shares Worth $2,297,945, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Leidos Holdings Insider Sold Shares Worth $2,297,945, According to a Recent SEC Filing

Aug 22, 2025 1:34 PM

04:11 PM EDT, 08/22/2025 (MT Newswires) -- Stephen Edward Hull, Sector President, on August 20, 2025, sold 12,890 shares in Leidos Holdings ( LDOS ) for $2,297,945. Following the Form 4 filing with the SEC, Hull has control over a total of 26,370 common shares of the company, with 26,370 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1336920/000162828025041021/xslF345X05/wk-form4_1755893363.xml

Previous page： Hudson Pacific Could Witness Momentum in Leasing as Operating Environment for West Coast Improves, BofA Says Next page： Thermo Fisher Scientific Gets US FDA Approval for Test to Identify Lung Cancer Patients for HERNEXEOS Therapy

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Hudson Pacific Could Witness Momentum in Leasing as Operating Environment for West Coast Improves, BofA Says

Aug 11, 2025

10:55 AM EDT, 08/11/2025 (MT Newswires) -- Hudson Pacific Properties ( HPP ) could witness continued momentum in office and studio leasing as the operating environment for the West Coast improves, BofA Securities said in a Monday research note. The company's recent equity raise offers management flexibility to ramp efforts on leasing its West Coast office portfolio as return-to-office trends...

Thermo Fisher Scientific Gets US FDA Approval for Test to Identify Lung Cancer Patients for HERNEXEOS Therapy

Aug 11, 2025

10:54 AM EDT, 08/11/2025 (MT Newswires) -- Thermo Fisher Scientific ( TMO ) said Monday it has received the US Food and Drug Administration's approval for its Oncomine Dx Target Test to help identify patients with non-small cell lung cancer who may be eligible for HERNEXEOS. The test detects HER2, or ERBB2, tyrosine kinase domain mutations in NSCLC tumors, allowing...

ResMed Insider Sold Shares Worth $2,238,379, According to a Recent SEC Filing

Aug 11, 2025

10:51 AM EDT, 08/11/2025 (MT Newswires) -- Michael J. Farrell, Chief Executive Officer, on August 07, 2025, sold 8,009 shares in ResMed ( RMD ) for $2,238,379. Following the Form 4 filing with the SEC, Farrell has control over a total of 457,593 common shares of the company, with 455,503 shares held directly and 2,090 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/943819/000094381925000038/xslF345X05/form4.xml...

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...